DIAZOXIDE
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01119 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 9 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | islet cell adenomatosis | TxGNN Knowledge Graph |
| 2 | Zollinger-Ellison syndrome | TxGNN Knowledge Graph |
| 3 | pancreatic insulinoma | TxGNN Knowledge Graph |
| 4 | pancreatic insulin-producing neuroendocrine tumor | TxGNN Knowledge Graph |
| 5 | congenital isolated hyperinsulinism | TxGNN Knowledge Graph |
| 6 | endocrine pancreas disease | TxGNN Knowledge Graph |
| 7 | hyperinsulinism (disease) | TxGNN Knowledge Graph |
| 8 | hyperinsulinemic hypoglycemia | TxGNN Knowledge Graph |
| 9 | hyperinsulinemic hypoglycemia, familial | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.